Breaking News
Top News
-
Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space
-
Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space
-
Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results
-
Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results
-
How the Iran war could crush the U.S. housing recovery, and it’s not just about mortgage rates
-
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases
-
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases
-
Mark Zuckerberg Explains Why Meta Just Made Its Latest Big Bet on Small Businesses
-
Analysts Sentiment on Biomea Fusion (BMEA) Remains Strong Amid Strong Diabetes Trial Results
-
Analysts Sentiment on Biomea Fusion (BMEA) Remains Strong Amid Strong Diabetes Trial Results
-
Wedbush Bullish on Black Diamond Therapeutics (BDTX) Following Progress in Silevertinib Program
-
Wedbush Bullish on Black Diamond Therapeutics (BDTX) Following Progress in Silevertinib Program
-
Strong Analyst Sentiment on Alight (ALIT) Amid Confident Management Commentary
-
Strong Analyst Sentiment on Alight (ALIT) Amid Confident Management Commentary
-
Stock Market Today: Major Indexes Rise, Oil Prices Slip After Report US Sends Iran Plan to End War
-
OpenAI Just Killed Sora, and It’s All Anthropic’s Fault
-
Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts
-
Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts
-
CervoMed (CRVO)’s Q4 Results Feature Advancements in Its Neflamapimod Program for Dementia Lewy Bodies (DLB)
-
CervoMed (CRVO)’s Q4 Results Feature Advancements in Its Neflamapimod Program for Dementia Lewy Bodies (DLB)
2026-02-05


































